QGENQiagen N.V.

HealthcareUSD
$42.39
Latest close: below its 200-day averageSep 8, 2026what changed →

Price

$42.39-13%1Y
1M+1.6%1Y-13%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
8/10
Value79
Quality89
Momentum28
Growth12
Strongest Quality, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

QIAGEN is a leading global provider of Sample to Insight solutions, enabling customers to extract and gain valuable molecular insights from samples containing the building blocks of life. Our Sample technologies isolate and process DNA (deoxyribonucleic acid), RNA (ribonucleic acid) and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis while bioinformatics software and knowledge bases can be used to interpret data to find actionable insights.

In the company’s own words · 20-F filed Mar 20, 2026 · SEC EDGAR

P/E (TTM)21.9
Market Cap$8.03B
1Y Return-13%
5Y Return-17%

For the full year FY2025, revenue was $2.09B (+5.7% year on year) and net income $425M.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Diagnostics & Research

Ranks #8 of 17 by Smart Score

Compare peers
TWST+2.5%
Twist Bioscience Corporation
ICLR-3.9%
ICON Public Limited Company
BLLN-0.28%
BillionToOne, Inc.
SHC-1.6%
Sotera Health Company
RDNT-2.3%
RadNet, Inc.
VCYT-0.15%
Veracyte, Inc.